Mechanism: gene expression at scale
A 2010 study in the Journal of Aging Research showed GHK-Cu modulates the expression of over 4,000 human genes, generally upregulating those involved in tissue repair and downregulating those involved in inflammation. The copper binding is essential — it enables redox reactions critical to collagen synthesis.
Skin research: collagen, elastin, and wrinkles
Topical GHK-Cu (typically 2% serum) and subcutaneous research dosing both show increased collagen and elastin synthesis. Published trials demonstrate measurable reductions in fine lines, improvements in skin density, and improved barrier function over 8–12 weeks. The effect builds gradually — daily consistency matters more than dose size.
Hair research
GHK-Cu has been studied for hair follicle stimulation, with research showing increased follicle size, prolonged anagen (growth) phase, and improved transplant survival in surgical studies. It is increasingly common in research-grade scalp formulations.
Wound healing
GHK-Cu's original discovery (Pickart, 1973) was as a wound-healing factor in human albumin. Subsequent research has documented accelerated closure of surgical wounds, diabetic ulcers, and burns when applied topically or injected near the site.
Dosing and protocol
Topical: 2% serum applied 1–2x daily. Subcutaneous research dosing: 1–2 mg per day. Both routes are well-tolerated; the systemic route is preferred when researching internal collagen (joint, tendon) effects rather than skin-surface effects.